MacroGenics
MGNX
#9393
Rank
A$0.13 B
Marketcap
A$2.06
Share price
-0.72%
Change (1 day)
-60.76%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.10 Billion

According to MacroGenics's latest financial reports the company has A$0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.18 B-16.7%
2023-12-31$A$0.22 B7.34%
2022-12-31$A$0.20 B-36.86%
2021-12-31$A$0.33 B-14.11%
2020-12-31$A$0.38 B16.82%
2019-12-31$A$0.32 B-4.46%
2018-12-31$A$0.34 B-10.05%
2017-12-31$A$0.38 B2.8%
2016-12-31$A$0.37 B-13.32%
2015-12-31$A$0.43 B190.23%
2014-12-31$A$0.14 B67.51%
2013-12-31$A$88.47 M-1216.12%
2012-12-31$-A$7.93 Million-53.52%
2011-12-31$-A$17.06 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Xencor
XNCR
A$0.94 B 833.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B 138,847.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$78.14 B 77,371.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$32.30 B 31,923.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.48 B 14,256.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.90 B 35,497.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B 27,660.78%๐Ÿ‡บ๐Ÿ‡ธ USA